Cargando…

PNPLA3 p.I148M and TM6SF2 p.E167K variants do not predispose to liver injury in cholestatic liver diseases: A prospective analysis of 178 patients with PSC

BACKGROUND: The adiponutrin (PNPLA3) p.I148M and transmembrane 6 superfamily member 2 (TM6SF2) p.E167K variants represent major genetic risk factors for progressive liver injury in nonalcoholic fatty liver disease (NAFLD), alcoholic liver disease (ALD) and chronic viral hepatitis. The aim of this st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kruk, Beata, Liebe, Roman, Milkiewicz, Małgorzata, Wunsch, Ewa, Raszeja-Wyszomirska, Joanna, Lammert, Frank, Milkiewicz, Piotr, Krawczyk, Marcin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6117000/ https://www.ncbi.nlm.nih.gov/pubmed/30161167 http://dx.doi.org/10.1371/journal.pone.0202942

Ejemplares similares

A common variant in the hepatobiliary phospholipid transporter ABCB4 modulates liver injury in PBC but not in PSC: prospective analysis in 867 patients
por: Kruk, Beata, et al.
Publicado: (2022)

Serum Autotaxin is a Marker of the Severity of Liver Injury and Overall Survival in Patients with Cholestatic Liver Diseases
por: Wunsch, Ewa, et al.
Publicado: (2016)

Vitamin D Receptor Polymorphisms Predispose to Primary Biliary Cirrhosis and Severity of the Disease in Polish Population
por: Kempińska-Podhorecka, Agnieszka, et al.
Publicado: (2012)

Heterozygous Inactivation of the Nuclear Receptor PXR/NR1I2 in a Patient With Anabolic Steroid-Induced Intrahepatic Cholestasis
por: Liebe, Roman, et al.
Publicado: (2016)

The Frequent Adiponutrin (PNPLA3) Variant p.Ile148Met Is Associated with Early Liver Injury: Analysis of a German Pediatric Cohort
por: Krawczyk, Marcin, et al.
Publicado: (2015)

Variant adiponutrin confers genetic protection against cholestatic itch
por: Krawczyk, Marcin, et al.
Publicado: (2014)

Leisure time physical activity and health-related behaviours after liver transplantation: a prospective, single-centre study
por: Kotarska, Katarzyna, et al.
Publicado: (2015)

Factors Affecting Health-Related Quality of Life and Physical Activity after Liver Transplantation for Autoimmune and Nonautoimmune Liver Diseases: A Prospective, Single Centre Study
por: Kotarska, Katarzyna, et al.
Publicado: (2014)

SARS-CoV-2 vaccination in liver transplant recipients: factors affecting immune response and refusal to vaccine
por: Raszeja-Wyszomirska, Joanna, et al.
Publicado: (2022)

TRAF1-C5 Affects Quality of Life in Patients with Primary Biliary Cirrhosis
por: Raszeja-Wyszomirska, Joanna, et al.
Publicado: (2013)

Factors Affecting Exercise Test Performance in Patients After Liver Transplantation
por: Kotarska, Katarzyna, et al.
Publicado: (2016)

Chronotropic incompetence in end-stage liver disease
por: Główczyńska, Renata, et al.
Publicado: (2022)

Validation of the BARD scoring system in Polish patients with nonalcoholic fatty liver disease (NAFLD)
por: Raszeja-Wyszomirska, Joanna, et al.
Publicado: (2010)

Etiology of Liver Disease and Cardiovascular Abnormalities in Patients on a Liver Transplantation Waiting List
por: Galas, Michalina, et al.
Publicado: (2019)

Ferroportin-related haemochromatosis associated with novel Y64H mutation of the SCL40A1 gene
por: Raszeja-Wyszomirska, Joanna, et al.
Publicado: (2014)

Pretransplant QT Interval: The Relationship with Severity and Etiology of Liver Disease and Prognostic Value After Liver Transplantation
por: Główczyńska, Renata, et al.
Publicado: (2018)

Orthotopic liver transplantation (OLTx) in non-cirrhotic portal hypertension secondary to ADAMTS13 deficiency
por: Raszeja-Wyszomirska, Joanna, et al.
Publicado: (2015)

Nutritional Strategies for the Individualized Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD) Based on the Nutrient-Induced Insulin Output Ratio (NIOR)
por: Stachowska, Ewa, et al.
Publicado: (2016)

Fine‐Tuning of Sirtuin 1 Expression Is Essential to Protect the Liver From Cholestatic Liver Disease
por: Blokker, Britt A., et al.
Publicado: (2019)

Long-Term Health-Related Quality of Life in Living Liver Donors
por: Janik, Maciej K., et al.
Publicado: (2019)

The Pre-Transplant Profile of Cardiovascular Risk Factors and Its Impact on Long-Term Mortality After Liver Transplantation
por: Główczyńska, Renata, et al.
Publicado: (2018)

Altered profiles of circulating cytokines in chronic liver diseases (NAFLD/HCC): Impact of the PNPLA3 ( I148M ) risk allele
por: Kirchmeyer, Mélanie, et al.
Publicado: (2023)

Mini-Mental State Examination in patients with hepatic encephalopathy and liver cirrhosis: a prospective, quantified electroencephalography study
por: Koziarska, Dorota, et al.
Publicado: (2013)

The Association between SOCS1−1656G>A Polymorphism, Insulin Resistance and Obesity in Nonalcoholic Fatty Liver Disease (NAFLD) Patients
por: Kempinska-Podhorodecka, Agnieszka, et al.
Publicado: (2019)

Gut Permeability Might be Improved by Dietary Fiber in Individuals with Nonalcoholic Fatty Liver Disease (NAFLD) Undergoing Weight Reduction
por: Krawczyk, Marcin, et al.
Publicado: (2018)

The additive effects of the TM6SF2 E167K and PNPLA3 I148M polymorphisms on lipid metabolism
por: Chen, Lizhen, et al.
Publicado: (2017)

Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women
por: Cherubini, Alessandro, et al.
Publicado: (2023)

PNPLA3 I148M associations with liver carcinogenesis in Japanese chronic hepatitis C patients
por: Nakaoka, Kazunori, et al.
Publicado: (2015)

PNPLA3-I148M: a problem of plenty in non-alcoholic fatty liver disease
por: BasuRay, Soumik
Publicado: (2019)

PNPLA3-I148M Variant Promotes the Progression of Liver Fibrosis by Inducing Mitochondrial Dysfunction
por: Gou, Yusong, et al.
Publicado: (2023)

Osteoporosis in primary biliary cirrhosis of the liver
por: Raszeja-Wyszomirska, Joanna, et al.
Publicado: (2014)

Good outcome following liver transplantation using pericardial-peritoneum window for hepato-atrial anastomosis to overcome advanced hepatic alveolar echinococcosis and secondary Budd-Chiari Syndrome - a case report
por: Kobryń, Konrad, et al.
Publicado: (2017)

Association of PNPLA3 I148M Variant With Chronic Viral Hepatitis, Autoimmune Liver Diseases and Outcomes of Liver Transplantation
por: Geng, Ning, et al.
Publicado: (2015)

Independent and joint correlation of PNPLA3 I148M and TM6SF2 E167K variants with the risk of coronary heart disease in patients with non-alcoholic fatty liver disease
por: Wu, Jian-Ting, et al.
Publicado: (2020)

MARC1 p.A165T variant is associated with decreased markers of liver injury and enhanced antioxidant capacity in autoimmune hepatitis
por: Janik, Maciej K., et al.
Publicado: (2021)

The i148m Pnpla3 polymorphism influences serum adiponectin in patients with fatty liver and healthy controls
por: Valenti, Luca, et al.
Publicado: (2012)

A Common Variant of PNPLA3 (p.I148M) Is Not Associated with Alcoholic Chronic Pancreatitis
por: Rosendahl, Jonas, et al.
Publicado: (2012)

Urinary Elimination of Bile Acid Glucuronides under Severe Cholestatic Situations: Contribution of Hepatic and Renal Glucuronidation Reactions
por: Perreault, Martin, et al.
Publicado: (2018)

Primary liver injury and delayed resolution of liver stiffness after alcohol detoxification in heavy drinkers with the PNPLA3 variant I148M
por: Rausch, Vanessa, et al.
Publicado: (2016)

Expression and Characterization of a PNPLA3 Protein Isoform (I148M) Associated with Nonalcoholic Fatty Liver Disease
por: Huang, Yongcheng, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_8dludi37lpkeqhm2kq7gb0ng67